Skip to main content
. 2009 Feb;250(2):371–377. doi: 10.1148/radiol.2502080498

Table 3.

GBCA Exposure and Interval between Exposure and Appearance of NSF Symptoms

graphic file with name r09fe11t03x.jpg

Note.—Data on time from index MR to first symptom were available for only 24 patients because records for three patients were incomplete regarding the date of the first symptom. For all other variables, data were available for 27 patients.

*

 The 1-week, 1-month, and 1-year cumulative doses are the sum of all GBCA doses administered to patients in the respective periods.

†

 P < .05 for comparison with the last gadolinium dose.